Author: Carter, Chris J.
Title: Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease Document date: 2017_9_28
ID: tmpidjrp_48
Snippet: It has also been noted that unaffected offspring with a parental history of AD have an enhanced inflammatory response in LPS-stimulated whole blood samples, producing higher levels of interleukin 1 beta, tumor necrosis factor alpha, and interferon gamma in response to LPS. This effect was independent of the APOE4 variant [138] suggesting that other AD genes are also endowed with gain of function in relation to the immune/inflammatory system. Mono.....
Document: It has also been noted that unaffected offspring with a parental history of AD have an enhanced inflammatory response in LPS-stimulated whole blood samples, producing higher levels of interleukin 1 beta, tumor necrosis factor alpha, and interferon gamma in response to LPS. This effect was independent of the APOE4 variant [138] suggesting that other AD genes are also endowed with gain of function in relation to the immune/inflammatory system. Monocyte-derived dendritic cells from AD patients also produce more interleukin-6 than those from healthy controls. AD monocytes stimulated with LPS also show a higher induced expression of the pro-inflammatory ICAM1 adhesion molecule than controls [139] . A⤠also stimulates cytokine production in peripheral blood mononuclear cells (PBMC) and the production of the chemokines, RANTES, MIP-1beta, and eotaxin as well as that of CSF2 (colony stimulating factor 2 (granulocyte-macrophage)) and CSF3 (colony stimulating factor 3) is greater than controls in AD-derived PBMC stimulated with A⤠[140] .
Search related documents:
Co phrase search for related documents- blood mononuclear cell and dendritic cell: 1, 2
- blood mononuclear cell and healthy control: 1, 2, 3, 4
- blood mononuclear cell and high level: 1, 2, 3
- blood mononuclear cell and immune inflammatory system: 1, 2, 3
- blood mononuclear cell and induced expression: 1, 2
- blood mononuclear cell and inflammatory response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- blood mononuclear cell and necrosis factor: 1, 2, 3, 4
- blood mononuclear cell and PBMC blood mononuclear cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53
- blood mononuclear cell and peripheral PBMC blood mononuclear cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54
- blood mononuclear cell and stimulating factor: 1
- blood mononuclear cell and tumor necrosis factor: 1, 2, 3
- blood mononuclear cell and tumor necrosis factor alpha: 1
- blood sample and healthy control: 1, 2, 3, 4, 5, 6
- blood sample and high level: 1, 2, 3, 4, 5
- blood sample and immune inflammatory system: 1
- blood sample and induced expression: 1
- blood sample and inflammatory response: 1, 2, 3, 4, 5, 6
- blood sample and necrosis factor: 1, 2, 3
- blood sample and tumor necrosis factor: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date